All Pharmaceuticals articles – Page 2
-
Blog
Amarin names chief legal and compliance officer
Pharmaceuticals company Amarin Corp. announced the appointment of Jonathan Provoost as executive vice president, chief legal and compliance officer.
-
News BriefNostrum Labs, CEO to pay up to $50M in DOJ false claims case
Pharmaceuticals firm Nostrum Laboratories and its founder and chief executive officer could pay up to $50 million as part of a settlement with the Department of Justice addressing alleged violations of the False Claims Act by underpaying Medicaid rebates.
-
Blog
Prime Therapeutics appoints chief compliance officer
Prime Therapeutics/Magellan Rx, a pharmacy benefit manager, announced the appointment of Tizgel High as chief compliance officer.
-
News BriefLawsuit: Pfizer fired, retaliated against whistleblower who raised FCPA concerns
An ex-Pfizer compliance officer is suing his former employer claiming wrongful termination and whistleblower retaliation after discovering the company allegedly paid $168 million to potentially influential government officials in China.
-
Blog
Earth Science Tech CCO resigns
Pharmaceuticals-geared holding company Earth Science Tech disclosed in a regulatory filing that Chief Compliance Officer Nickolas Tabraue resigned.
-
News BriefInotiv discloses FCPA probe into primate importation practices
Inotiv disclosed the Securities and Exchange Commission is investigating potential violations of the Foreign Corrupt Practices Act by the pharmaceutical testing company regarding its importation of nonhuman primates from Asia.
-
News BriefCCO among 12 individuals charged in DOJ, SEC insider trading sweep
The Department of Justice and Securities and Exchange Commission announced charges against a dozen individuals across four separate insider trading cases, including an alleged scheme involving the chief compliance officer of an international payment processing company.
-
News BriefPharmacy holding company CCO convicted in $50M Medicare fraud
Steven King, the chief compliance officer of a defunct pharmacy holding company, was found guilty of conspiracy to commit healthcare fraud and wire fraud for unnecessarily billing Medicare for more than $50 million in medical supplies.
-
PremiumCCO compensation survey: Big gains for energy, healthcare
Annual total compensation for chief compliance officers rose 10 percent in 2022, according to the latest compensation survey by executive search firm BarkerGilmore.
-
Blog
Eiger appoints general counsel, chief compliance officer
Eiger BioPharmaceuticals announced the appointment of James Vollins as general counsel, chief compliance officer, and corporate secretary.
-
News BriefEx-CCO of Rochester Drug Co-operative spared jail time after testifying
The former chief compliance officer of Rochester Drug Co-operative received no jail time after pleading guilty to aiding widescale opioid distribution and testifying against his former chief executive officer.
-
News BriefDOJ intervenes in suit alleging Rite Aid helped fuel opioid crisis
The Department of Justice announced its intervention in a lawsuit alleging retail pharmacy chain Rite Aid filled hundreds of thousands of prescriptions for medically unnecessary oxycodone and other opioids in violation of multiple federal laws.
-
Blog
Catalent appoints general counsel, chief compliance officer
Catalent, a pharmaceuticals manufacturer and consumer health products company, announced the appointment of Joseph Ferraro as senior vice president, general counsel, chief compliance officer, and secretary.
-
News BriefWalgreens to pay $7M for accepting alleged FCA violation proceeds
Walgreens agreed to pay $7 million to settle alleged violations of the False Claims Act that it overbilled the state of Tennessee’s Medicaid insurance program for Hepatitis C medications and kept the proceeds even after it discovered an employee’s misconduct.
-
ArticleWalmart to pay $3.1B in nationwide opioid settlement
Walmart announced it agreed to a $3.1 billion nationwide settlement designed to resolve all the potential state lawsuits it faces for its alleged role in fueling the opioid epidemic.
-
ArticleEx-Mylan chief information officer charged over insider trading scheme
The chief information officer at former pharmaceutical company Mylan was charged with insider trading for tipping off a former colleague about the firm’s impending merger with a division of Pfizer, among other matters.
-
ArticleDermaTran, other pharmacies settle with DOJ over pain cream false claims
DermaTran Health Solutions, its related pharmacy billing company, and three retail pharmacies agreed to pay more than $6.8 million to settle alleged violations of the False Claims Act for charging patients in federal health programs extra for pain relief creams.
-
ArticlePharma, whistleblower lessons learned from $900M Biogen settlement
Experts discuss the ramifications of Biogen’s $900 million settlement for False Claims Act violations, including the $266.4 million whistleblower bounty in the case believed to be the largest single award under any government program.
-
ArticleSEC charges pharma CEO, 2 companies with offering fraud
The Securities and Exchange Commission charged Paul Edalat and two pharmaceuticals companies he controlled—Sentar and Vivera—with engaging in a fraudulent investment scheme.
-
PremiumExperts: Where to start on your ESG journey
ESG directors from Tenneco and Amneal Pharmaceuticals shared best practices for businesses broaching the initial phases of environmental, social, and governance reporting at CW’s virtual ESG Summit.